148 related articles for article (PubMed ID: 7520381)
1. Platelet-activating factor mediates pancreatic function derangement in caerulein-induced pancreatitis in rats.
Alonso R; Montero A; Arévalo M; García LJ; Sánchez-Vicente C; Rodríguez-Nodal F; López-Novoa JM; Calvo JJ
Clin Sci (Lond); 1994 Jul; 87(1):85-90. PubMed ID: 7520381
[TBL] [Abstract][Full Text] [Related]
2. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.
Konturek SJ; Dembinski A; Konturek PJ; Warzecha Z; Jaworek J; Gustaw P; Tomaszewska R; Stachura J
Gut; 1992 Sep; 33(9):1268-74. PubMed ID: 1385272
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist.
Fujimura K; Kubota Y; Ogura M; Yamaguchi T; Binnaka T; Tani K; Kitagawa S; Mizuno T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):199-202. PubMed ID: 1571504
[TBL] [Abstract][Full Text] [Related]
4. Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model.
Ais G; López-Farre A; Gomez-Garre DN; Novo C; Romeo JM; Braquet P; López-Novoa JM
Gastroenterology; 1992 Jan; 102(1):181-7. PubMed ID: 1727752
[TBL] [Abstract][Full Text] [Related]
5. Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats.
Griesbacher T; Kolbitsch C; Tiran B; Lembeck F
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):557-64. PubMed ID: 8751086
[TBL] [Abstract][Full Text] [Related]
6. Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin.
San Román JI; De Dios I; Manso MA; Calvo JJ; López MA
Arch Int Physiol Biochim; 1990 Oct; 98(5):237-43. PubMed ID: 1708991
[TBL] [Abstract][Full Text] [Related]
7. The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals.
Dabrowski A; Gabryelewicz A; Chyczewski L
Int J Pancreatol; 1991 Jan; 8(1):1-11. PubMed ID: 2033314
[TBL] [Abstract][Full Text] [Related]
8. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
9. Effect of PAF antagonists on cerulein-induced pancreatitis.
Jancar S; Abdo EE; Sampietre SN; Kwasniewski FH; Coelho AM; Bonizzia A; Machado MC
J Lipid Mediat Cell Signal; 1995 Jan; 11(1):41-9. PubMed ID: 7537159
[TBL] [Abstract][Full Text] [Related]
10. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.
Dabrowski A; Gabryelewicz A; Chyczewski L
Int J Pancreatol; 1995 Apr; 17(2):173-80. PubMed ID: 7542692
[TBL] [Abstract][Full Text] [Related]
11. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor.
Jancar S; De Giaccobi G; Mariano M; Mencia-Huerta JM; Sirois P; Braquet P
Prostaglandins; 1988 May; 35(5):757-70. PubMed ID: 2969600
[TBL] [Abstract][Full Text] [Related]
12. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis.
Sandoval D; Gukovskaya A; Reavey P; Gukovsky S; Sisk A; Braquet P; Pandol SJ; Poucell-Hatton S
Gastroenterology; 1996 Oct; 111(4):1081-91. PubMed ID: 8831604
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.
Ogura M; Kubota Y; Inoue K
J Gastroenterol; 1996 Jun; 31(3):414-9. PubMed ID: 8726834
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor attenuates pancreatic damage in caerulein-induced pancreatitis in rats.
Warzecha Z; Dembiński A; Konturek PC; Ceranowicz P; Konturek SJ; Tomaszewska R; Schuppan D; Stachura J; Nakamura T
Eur J Pharmacol; 2001 Oct; 430(1):113-21. PubMed ID: 11698071
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of pancreas to repeated caerulein-induced pancreatitis in rats.
Dembinski A; Warzecha Z; Konturek PC; Ceranowicz P; Konturek SJ; Tomaszewska R; Stachura J
J Physiol Pharmacol; 1996 Sep; 47(3):455-67. PubMed ID: 8877901
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis.
Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I
Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor involvement in the aggravation of acute pancreatitis in rabbits.
Yotsumoto F; Manabe T; Kyogoku T; Hirano T; Ohshio G; Yamamoto M; Imamura T; Yoshitomi S
Digestion; 1994; 55(4):260-7. PubMed ID: 7520402
[TBL] [Abstract][Full Text] [Related]
19. Role of sensory nerves in pancreatic secretion and caerulein-induced pancreatitis.
Warzecha Z; Dembiński A; Jaworek J; Ceranowicz P; Szlachcic A; Walocha J; Konturek SJ
J Physiol Pharmacol; 1997 Mar; 48(1):43-58. PubMed ID: 9098825
[TBL] [Abstract][Full Text] [Related]
20. Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis.
Szczerbiński M; Celiński K; Słomka M; Kasztelan-Szczerbińska B; Cichoz-Lach H
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):245-56. PubMed ID: 12898930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
